G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2006
12/14/2006	WO2006131379A2 Method for testing substances or mixtures of substances, use of said method and corresponding test kits
12/14/2006	WO2006131225A1 Method and device for the quantitative determination of analytes in liquid samples
12/14/2006	WO2006131097A2 Method for the imaged representation of physiological taste sensations of bouquet and colour in particular for the description of wines
12/14/2006	WO2006131080A1 Protein microarrays for immunodiagnostics
12/14/2006	WO2006131013A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα
12/14/2006	WO2006131008A1 Device for using with a sensor for improving accuracy, and sensor with an improved accuracy
12/14/2006	WO2006130990A2 Detecting electrical activity and assessing agents for the ability to influence electrical activity in neuronal cell networks
12/14/2006	WO2006130955A1 Polymer compositions and uses thereof
12/14/2006	WO2006130921A1 Investigating biological cells using enhanced raman spectroscopy
12/14/2006	WO2006111586A3 Method for the in vitro determination of the degree of methylation of the line-1 promoter
12/14/2006	WO2006110827A3 Constricting gel assay and therapeutic patch
12/14/2006	WO2006110441A3 Lectin binding to choroidal neovascularization
12/14/2006	WO2006108248A3 In vitro method for simultaneously detecting and identifying antibiotics of different classes and corresponding diagnostic kit
12/14/2006	WO2006105486A3 Novel tumor suppressor gene and compositions and methods for making and using the same
12/14/2006	WO2006103450A3 Electrochemical assay
12/14/2006	WO2006095181A3 Biosensor labelling groups
12/14/2006	WO2006094673A3 Synergistic mixtures of c6- to c12-alkanedi0ls and tropolone (derivatives)
12/14/2006	WO2006091421A3 Peptides for detection of antibody to ehrlichia ewingii
12/14/2006	WO2006084299A3 Method for evaluating the allergen sensitivity of an individual
12/14/2006	WO2006076265A3 Method and device for decreasing contamination
12/14/2006	WO2006076034A3 Stabilized two component system for chemilumiescent assay in immunodiagnostics
12/14/2006	WO2006071946A3 Electrically active combinatorial-chemical (eacc) chip for biochemical analyte detection
12/14/2006	WO2006071469A3 Modulation of the neuroendocrine system as a therapy for amyotrophic lateral sclerosis
12/14/2006	WO2006060652A3 Methods and devices for detecting pancreatic lipase
12/14/2006	WO2006047182A8 Method and apparatus for determining an analyte concentration in a sample having interferents
12/14/2006	WO2006044650A3 Competitive differential screening
12/14/2006	WO2006036388B1 Systems and methods for detecting and analyzing polymers
12/14/2006	WO2006028916A3 Novel stable lipid standards
12/14/2006	WO2006007444A3 CaMKII/CALCIUM CHANNEL BINDING-RELATED COMPOSITIONS AND METHODS
12/14/2006	WO2005103712A3 Use of precursors of tachykinins and/or their fragments in medical diagnostic
12/14/2006	WO2005098446A3 Biomarkers for ovarian cancer
12/14/2006	WO2005095461A3 Gold-binding protein and use thereof
12/14/2006	WO2005040759A3 Apparatus and methods for detecting target analyte
12/14/2006	WO2005007116A3 Artificial antigen presenting cell devices
12/14/2006	WO2005003764A3 Assay for detecting atrial and brain natriuretic peptide prohormones
12/14/2006	WO2004067721A3 Tkts as modifiers of the beta-catenin pathway and methods of use
12/14/2006	WO2004055165A3 Glutathione-s-transferase test for susceptibility to parkinson's
12/14/2006	WO2004006861A3 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
12/14/2006	WO2003033722A3 Nucleic acid amplification methods
12/14/2006	US20060282909 Methods and compositions for therapeutic intervention in cardiac hypertrophy
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060281902 Human signal peptide-containing proteins
12/14/2006	US20060281900 Lepidoptera voltage-gated calcium channels
12/14/2006	US20060281899 Mutants of biotin binding protein
12/14/2006	US20060281776 Isotope labeled camptothecin derivatives
12/14/2006	US20060281699 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/14/2006	US20060281697 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
12/14/2006	US20060281687 Cyclin groove inhibitors
12/14/2006	US20060281195 Using agglutination complex comprising magnetic particles to measure concentration of virulent proteins in bodily fluids; immunoassay
12/14/2006	US20060281194 Magnetic field and field gradient enhanced centrifugation solid-liquid separations
12/14/2006	US20060281193 Non-optical reading of test zones
12/14/2006	US20060281191 Method for monitoring organic deposits in papermaking
12/14/2006	US20060281189 Diagnostic detection device and method
12/14/2006	US20060281186 Indicator composition
12/14/2006	US20060281185 Detection of analytes in aqueous environments
12/14/2006	US20060281181 Adaptor-directed helper systems
12/14/2006	US20060281179 Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
12/14/2006	US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006	US20060281146 Novel compositions and methods for the treatment of immune related diseases
12/14/2006	US20060281140 Coagulation tests at ambient temperature
12/14/2006	US20060281139 Carrier and method for the detection of anti-borrelia antibodies and test kit for use in the diagnosis of Lyme borreliosis infections
12/14/2006	US20060281138 Methods for diagnosis of low grade astrocytoma
12/14/2006	US20060281137 Method of the discrimination and isolation of mammary epithelial stem and colony-forming cells
12/14/2006	US20060281136 Preparation of endodermal stem cells
12/14/2006	US20060281135 Methods for diagnosing and treating cerebrovascular events based on NR2 peptides
12/14/2006	US20060281134 Method for analyzing biological data sets
12/14/2006	US20060281133 Targeted fusion proteins and methods for the characterization of cellular membrane domains
12/14/2006	US20060281132 Method of immunoreaction measurement and, for use therein, reagent, kit and optical cell
12/14/2006	US20060281131 Monoclonal antibodies; renal diseases; kits
12/14/2006	US20060281130 Metod of modulation of interaction between receptor and ligand
12/14/2006	US20060281129 Method for detecting biopolymers
12/14/2006	US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/14/2006	US20060281124 Device and method for purification of biological materials
12/14/2006	US20060281122 Methods for the identification, assessment, and treatment of patients with cancer therapy
12/14/2006	US20060281117 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-1G subunit (CACNA1G)
12/14/2006	US20060281116 In situ heat induced antigen recovery and staining apparatus and method
12/14/2006	US20060281114 Methods and compositions for assessment of pulmonary function and disorders
12/14/2006	US20060281111 isolated polyclonal antibody of given sequence; use in detecting, diagnosing, staging or monitoring progression of cancer, inflammatory, autoimmune, cardiovascular, and neurological disorders
12/14/2006	US20060281104 Leuco dye particles and uses thereof
12/14/2006	US20060281102 Methods for detecting genetic haplotypes by interaction with probes
12/14/2006	US20060281101 Biobriefcase
12/14/2006	US20060281095 44 human secreted proteins
12/14/2006	US20060281093 Erbb receptor methods and kits for monitoring chemotherapy resistance
12/14/2006	US20060281091 Genes regulated in ovarian cancer a s prognostic and therapeutic targets
12/14/2006	US20060281089 Detecting presence of mutant bcl gene of given sequence; identifying patients resistant to chemotherapy or radiation treatments
12/14/2006	US20060281088 Markers for lxr activation
12/14/2006	US20060281087 Titanium dioxide complex having molecule distinguishability
12/14/2006	US20060281085 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
12/14/2006	US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006	US20060281078 Human fast-1 gene
12/14/2006	US20060281077 Spectrophotometric evaluation of bodily fluid; genome analysis and diagnostics; detecting binding or cleavage of one or more specific binding substances to the colorimetric resonant reflectance optical biosensor surface, or to their respective binding partners which are immobilized
12/14/2006	US20060281076 Substrate functionalization method for high sensitivity applications
12/14/2006	US20060281074 Affinity-based detection of biological targets
12/14/2006	US20060281072 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy
12/14/2006	US20060281069 Classifying activity of membrane protein modulators; obtain cells, expose to modulators, pulse cells with electricity, detecting fluorescence emission from cells
12/14/2006	US20060280931 Multi-layer coated porous materials and methods of making the same
12/14/2006	US20060280754 Especially arenaviruses, coronaviruses, filoviruses, orthomyxoviruses, paramyxoviruses, and retroviruses
12/14/2006	US20060280747 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
12/14/2006	US20060280741 Administering the antibody concurrently with an antagonist of IL-1 alpha to treat psoriatic arthritis; arthritis nodosa; seronegative spondylarthropathy, and ulcerative colitis
12/14/2006	US20060280739 Novel human beta-2 integrin alpha subunit

1 ... 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 ... 3937